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were observed. After repeated inflations with high pressure the residual 
area stenosis was reduced only marginally (20 ± 21%; n.s.). Based on IU 
assessment of the reference area, the balloon size for slant expansion could 
be increased by at least 0.5 mm diameter in 26°/,, of cases. This lead to an 
ircrease of SAtu from 6.30 -,- 1.35 mm '~ to 8.40 ± 1.70 mms (p < 0.001), 
and to a reduction of the residual area stenosis to 5 :t: 20% (p < 0.001). Still, 
SAIu reached only 77 :l: 15% of SABA. Before IU, only 38% of stsnts had a 
residual area stenosis less than 20%; after IU optimization, this fraction of 
stents was increased to 56%. 
• After initial high-pressure stont expansion IU revealed a considerable resld- 
ual stenosis, and in 8% protruding stont struts. The assessment of stents by 
IU lead to a significant increase of the stant area due to optimized balloon 
sizes in one fourth of cases. Thus, IU further improved the luminal area gain 
by stenting even after high pressure deployment. 
Endothelial Hyperplasla and Reatenosis Depend 
on the Technique of Coronary 5tent Implantation 
R Buszman, R. Stables, U. Sigwad, R Senuys on behalf of the 
BENESTENT Study Group. Royal Brompton Hospital, London, UK; 
Thoraxcenter, Erasmus University Rotterdam, The Netherlands 
In the animal model of restenosis, the mechanical stretch of artery wall after 
stont implantation activates mooth muscle cell and endothelial hyperplasia. 
Therefore the aim of our study was to assess the influence of slant implan- 
tation technique on restenosis rate in the population of patients included in 
BENESTENT I •al. 
Methods. 223 patients after pdmary slant implantation (PS) and 217 after 
routine coronary angioplasty (PTCA) were included into the study. Quantita- 
tive coronary angiogrem was performed before and just after the procedure. 
Additional QCA was taken after 6 month follow-up. From those angiogrems 
reference vessel diameter (Refl, 2, 3), minimal luminal diameter (MLD1,2, 3) 
residual stenosis (ReSt) and luminal diameter stanoals after six months (i.e. 
restenosis, Rest) were measured. Multivariate regression analysis (MRA) 
was applied to determine relation of maximal inflation pressure (MaxPress), 
maximal balloon diameter (Bal) and ratio Bal/Refl to late loss of minimal 
luminal diameter (LL = MLD2.-MLD3) and restonosis (Rest). 
Results. In both groups of patients significant enlargement of reference 
diameter was observed after beth preceduros (Refl vs Ref2: p < 0.001) and 
the ratio Refl/Ref2 correlated well to LL (r = 0.19, p < 0.001). In PS group, 
MRA showed that LL was significantly related (p = 0.0003, F = 4.95, R = 0.32) 
to ReSt (-0.17), Bal/Refl (+0.169) and MaxPress (-0.07). Furthermore, the 
model of Rest (p = 0.03, R = 0.2038, F = 3.03) included: MLD2 (-0.21), Refl 
(+0.114) and MaxPress (-0.09). 
Conclusions: To obtain optimal ate result, high pressure and possibly the 
smallest balloon diameter giving full slant expansion should be used for 
coronary slant delivery. 
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• L inkage o f  Autosomal Dominant Familial Dilated 
Cardlomyopathy to Chromosome 9 
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Giovanni Maria Sevednl, Jelana Milasin, Arturo Falaschi, Fuivio Camedni, 
Mauro Giacoa, Luiaa Msstronl, and the Heart Muscle Disease Study Group. 
International Centre for Genetic Engineering and Biotechnology, University 
Hospital, Trieste, italy 
Idiopathic dilated cardiomyopethy is a heart muscle disease of unknown 
etiology, characterized by impaired myocardial contractility and ventdcular 
dilatation. Familial transmission is often recognized (FDC), mostly with auto- 
somal dominant Inhedtance. 
In order to understand the molecular genetic basis of the disease, a large 
six-generation kindred with autasomal dominant FDC was studied for linkage 
analysis. Eighty family members were Investigated and the disease status 
was established after a clinical follow-up of 3 years. According to stdct diag- 
nostic cdtada, 13 members were considered to be affected, and 2 of unknown 
status, while members under the age of 16 were excluded from the linkage 
study to avoid the low penstrance of this age group. The analysis was then 
extended to two other Informative families with autosomal dominant pattern 
of transmission and identical clinical features (with 8 affected members, and 
1 of unknown status). 
A genome wide search was undertaken after a large sedes of candidate 
genes were excluded. Co-inheritance of the disease gene was excluded for 
over 95% of the ganome, analyzing 251 polymoq~hio markers. Linkage was 
found for chromosome 9(:113-q22, with a maximum cumulative two-point led 
score of 3.69 (locus d9S153, at O = 0.08) and a maximum muiflpotnt led 
score of 4.2. There was no evidence of heterogeneity. According to the two- 
point, muitipeint and hoplotypa nalyses, the gene for FDC in these families 
was placed in the interval between loci D9S153 and 095152. 
A gene for autosomal dominant FDC was localized on the long arm of 
chromosome 9: several candidate genes for causing dilated cardiomyopathy 
map in this region. 
~ - ' ~  A Point Mutation in the 5' Splice Site o f  the Fl int 
Intron of  the Dystrophln Gene Responsible for  
X-Unked Dilated Cardiomyopathy 
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Lucia Bartoloni, MatteD Vatta, Maja Krajinovi¢, Con'ado Angalini, 
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X-linked dilated canJiomyopathy (XLDC) is a familial heart disease presenting 
in young males as a r'4pidly progressive congestive heart failure, without 
clinical signs of skeletal myopathy. This condition has recently been linked 
to the dystrophin gene in some families, and deletions encompassing the 
region of the first muscle exon have been detected. In order to identify the 
defect responsible for this disease at the molecular level, a family with a 
severe form of XLDC was studied. In the affected members, no deletions of 
the dystmphln gane were observed. Analysis of the muscle promoter, first 
exon and intron regions revealed the presence of a single point mutation 
at the first exon-intron boundary, removing the universally conserved 5' 
splice site consensus sequence of the first intren. This mutation introduces 
a new restriction site for Mse I, which cosegregatss with the disease in 
this family. Expression of the major dystmphin mRNA isoforms (from the 
muscle-, brain- and Purkinje cell-promoters) was completely abolished in the 
myocardium, while the brain- and PurkinJe cell-0out not the muscle-) iaoforms 
were detectable in the skeletal muscle. Immuncoytochemical studies with 
anti-dyalmphin antibodies howed that the protein was reduced in quantity 
but normally distributed in the skeletal muscle, white it was undetectable in 
the cardiac muscle. 
These findings indicate that expression of the muscle dystrophin isoform is 
cdtical for myocardial function, and suggest that selective heart involvement 
in dystrophin-linked dilated cardiomyopathy is related to the absence in the 
heart of compensatory expression of dystrophin from alternative promoters. 
~ '~"~ Angiotensinogen Genotype Is Auo¢ la ted  With 
Myocardial Cell Hypertrophy in Patients With 
Idiopathic Dilated Cardlomyopathy 
Hiroya Sakuramoto, Yoshiyuki Yokota, Mofoshi Takeuchi, Hiroya Kawai, 
Tat.sum Ishida, Tswoshi Sakeda, Seinosuke Kawashima, Hozuka Akita, 
Mitsuhiro Yokoyama. Kobe University,, Kobe, Japan 
Recent in vitro studies demonstrate that anglotansln IIcauses myocyte hyper- 
trophy and fibmblast proliferation. An angiotansin-converting enzyme (ACE) 
qenotypa and angtotanslnugen (AGT) genotype have been reported to be 
associated with heart failure in cardiomyopathy and left ventdcular (LV) 
hypertrophy in hypertension, respectively. However, whether the polymor- 
phlsms of these two genes are asscciatod with human cardiac histology has 
not yet been shown. To assess these relations, we studied 44 patlenta with 
idiopathic dilated cardiomyopathy (IDC) at the early stage of hear~ failure. 
Myocyte transverse diameter (ME)) and the extent of fibrosis (%F) were eval- 
uated In endomyocardial biopsy specimens from the Intsrventdcutar septum 
of the right ventricle. The pelymorphlsms of the ACE gene and the AGT gene; 
M235T and T174M, were determined. 
M174T:1"rvsnon'rr "r235M:T1"vsnon1"r ACE:IlvslDvsDD 
MD (~m) 18 :E3 vs 23~ 4~ 1a~4 vs 20..~8 lg =1:3 vs lg :/: 6 t.'s la ± 3 
%F(%) lS±Svs 15:1:4 15:1:6 vs 17-,-6 16-,-6 v= 17 :E5 vs 1 ~ 4- 7 
§p < 0.001 vS 11" 
The T174M variant of the AGTgena (p < 0.001 )and LV ajectional fraction (p 
< 0.05) were independent predictors of MD by a multiple regression analysis. 
In conclusion, the T174M variant of AGT gene, but not ACE genotype Is 
associated with myocardial cell hypertrophy in IDC patients. 
